{"entity":{"id":"steven-k-libutti","kind":"person","name":"Steven K. Libutti","aka":[],"tldr":"Surgeon who directs Rutgers Cancer Institute of New Jersey, the state's NCI-designated comprehensive cancer centre.","summary":"Steven K. Libutti, MD, FACS, is Director of Rutgers Cancer Institute of New Jersey, which holds National Cancer Institute designation as a Comprehensive Cancer Center. He is a Fellow of the American College of Surgeons and runs the Libutti Laboratory within the institute's resident faculty research programme. The institute's website lists him at the head of its leadership and publishes a message from the Director under his name.","asOf":"2026-09-10","wikipedia":"https://en.wikipedia.org/wiki/Steven_Libutti","links":[{"label":"Source: Rutgers Cancer Institute leadership profile","url":"https://www.cinj.org/about-cinj/steven-k-libutti-md-facs"},{"label":"Rutgers Cancer Institute home page naming the Director","url":"https://www.cinj.org/"}],"tags":["leadership","clinician-scientist","comprehensive-cancer-centre"],"related":[],"cancers":["neuroendocrine"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["rutgers-cinj"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Director, Rutgers Cancer Institute of New Jersey","institutionId":"rutgers-cinj","specialisms":["Surgical oncology","Endocrine and neuroendocrine tumours","Cancer centre leadership"],"profiles":[{"label":"Rutgers Cancer Institute profile","url":"https://www.cinj.org/about-cinj/steven-k-libutti-md-facs"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Libutti+SK%5BAuthor%5D"}],"papers":[{"title":"Management of Other Gastric and Duodenal Neuroendocrine Tumors","journal":"Surgical Oncology Clinics of North America","year":2020,"doi":"10.1016/j.soc.2019.11.009"},{"title":"B7 immune-checkpoints as targets for the treatment of neuroendocrine tumors","journal":"Endocrine-Related Cancer","year":2021,"doi":"10.1530/erc-20-0337"},{"title":"Association of VHL Genotype With Pancreatic Neuroendocrine Tumor Phenotype in Patients With von Hippel–Lindau Disease","journal":"JAMA Oncology","year":2018,"doi":"10.1001/jamaoncol.2017.3428"}]},"route":"/people/steven-k-libutti/","neighbours":{"cancer":[{"id":"neuroendocrine","kind":"cancer","name":"Neuroendocrine tumours","route":"/cancers/neuroendocrine/"}],"institution":[{"id":"rutgers-cinj","kind":"institution","name":"Rutgers Cancer Institute of New Jersey","route":"/institutions/rutgers-cinj/"}]}}